Wondfo Brand Ranking

Wondfo

Wondfo Biotech Co., Ltd.

Industry： Medical devices , Blood glucose meter , Antigen detection , In vitro diagnosis

If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.

Wondfo

Wondfo Biotech Co., Ltd.

Industry： Medical devices , Blood glucose meter , Antigen detection , In vitro diagnosis

If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.

Brand Introduction

Guangzhou Wanfu Biotechnology Co., Ltd. (stock code: 300482) was founded in 1992 and is headquartered in Guangzhou Science City. It was listed on the Shenzhen Stock Exchange GEM on June 30, 2015.

Wanfu Bio's business is concentrated in the field of in vitro diagnosis under the medical device sector, specializing in the research and development, production and intelligent manufacturing, marketing and services of fast diagnostic reagents and supporting instruments of instant testing/bedside testing. It is a domestic POCT One of the leading companies. The products are sold to more than 140 countries and regions around the world and are widely used in clinical testing, critical and severe diseases, chronic disease management, primary medical care, epidemic monitoring, disaster rescue, on-site law enforcement and family personal health management.

Wanfu Bio has successively won the National Torch Program Key High-tech Enterprise, National Enterprise Technology Center, National Bioengineering High-tech Industrialization Demonstration Base, National Intellectual Property Advantage Enterprise, World Health Organization PQ Certified Enterprise, and World Customs Organization AEO Senior Certified Enterprise. One of the domestic in vitro diagnostic reagent companies that have passed the on-site audit of the US FDA.

The company currently has set up R&D centers in Guangzhou, Shenzhen, China, and San Diego, USA. It has more than 800 R&D personnel, all of which are professionals in the fields of biochemistry, clinical medicine, microelectronics technology, etc. The intensity of R&D investment and R&D team strength are both in the industry's advanced position.

After 30 years of development, the company has built a relatively complete technology platform and product line, and is an enterprise with a wide range of technology platform layouts and rich product lines among domestic POCT enterprises. The company has existing immunocolloid gold technology platform, immunofluorescence technology platform, electrochemical technology platform, dry biochemical technology platform, chemiluminescence technology platform, molecular diagnostic technology platform, pathological diagnosis technology platform, as well as instrument technology platform and biological raw material platform, and Relying on the above nine technical platforms, a rich product line has been formed in the field of cardiovascular and cerebrovascular diseases, inflammation, tumors, infectious diseases, viral testing (drug abuse), eugenics and other testing fields.

As of December 31, 2021, the company has obtained a total of 540 product registration certificates such as NMPA, FDA, CE, and Canadian MDALL, ranking among the top in the industry.

Related Keywords: Wondfo Medical devices , Wondfo Blood glucose meter , Wondfo Antigen detection , Wondfo In vitro diagnosis